Assignee
FERRING BV
US156 patents
Top patents by PatentIndex Score
US6214798B1Apr 10, 2001
GnRH antagonists being modified in positions 5 and 6
FERRING BV62 citations96
US6201132B1Mar 13, 2001
Inhibitors of DP-mediated processes, compositions, and therapeutic methods thereof
FERRING BV149 citations96
US5939560AAug 17, 1999
Inhibitors of DP-mediated processes, compositions and therapeutic methods thereof
FERRING BV253 citations96
US5925730AJul 20, 1999
GnRH antagonists
FERRING BV60 citations96
US5821230AOct 13, 1998
GnRH antagonist decapeptides
FERRING BV57 citations96
US7560429B2Jul 14, 2009
Orodispersible dosage forms of desmopressin acetate
FERRING BV24 citations94
US6143722ANov 7, 2000
Heptapeptide oxytocin analogues
FERRING BV74 citations94
US5763398AJun 9, 1998
Nasal administration of desmopressin
FERRING BV50 citations94
US6911467B2Jun 28, 2005
Antidiabetic agents
FERRING BV19 citations92
US6521644B1Feb 18, 2003
Compositions for promoting growth
FERRING BV62 citations92
US5990273ANov 23, 1999
Synthesis of cyclic peptides
FERRING BV74 citations91
US5965701AOct 12, 1999
Kappa receptor opioid peptides
FERRING BV84 citations91
US5922680AJul 13, 1999
Stabilized composition for oral administration of peptides
FERRING BV75 citations91
US5725872AMar 10, 1998
Composition for foams, notably rectal foams, and foams thus obtained
FERRING BV115 citations91
USD815734SApr 17, 2018
Medicine applicator
FERRING BV15 citations90
US9579359B2Feb 28, 2017
Method of treating prostate cancer with GnRH antagonist
FERRING BV14 citations90
US7947654B2May 24, 2011
Pharmaceutical formulations
FERRING BV9 citations90
US10172906B2Jan 8, 2019
Manufacture of Degarelix
FERRING BV11 citations89
US9592266B2Mar 14, 2017
Manufacture of degarelix
FERRING BV11 citations89
US7074781B2Jul 11, 2006
Condensed azepines as vasopressin agonists
FERRING BV30 citations89
US6664249B1Dec 16, 2003
Bicyclic vasopressin agonists
FERRING BV25 citations89
US5763407AJun 9, 1998
High-purity desmopressin produced in large single batches
FERRING BV34 citations89
US6844180B2Jan 18, 2005
Serine protease genes related to DPPIV
FERRING BV15 citations88
US5780434AJul 14, 1998
Composition for oral administration of peptides
FERRING BV37 citations88
US5047398ASep 10, 1991
DDAVP antidiuretic and method therefor
FERRING BV63 citations88
US5763405AJun 9, 1998
Stabilized composition for oral administration of peptides
FERRING BV43 citations87
US7094545B2Aug 22, 2006
Pharmaceutical composition as solid dosage form and method for manufacturing thereof
FERRING BV29 citations86
US7022340B2Apr 4, 2006
Pharmaceutical composition as solid dosage form and method for manufacturing thereof
FERRING BV30 citations86
US5985835ANov 16, 1999
Desmopressin for nocturia, incontinence and enuresis
FERRING BV30 citations86
US5698516ADec 16, 1997
Biologically active vasopressin analogues
FERRING BV43 citations86
US7018653B2Mar 28, 2006
Method for preparing solid dosage form of desmopressin
FERRING BV29 citations85
US11292824B2Apr 5, 2022
Pharmaceutical preparation comprising recombinant hCG
FERRING BV3 citations83
US10526390B2Jan 7, 2020
Pharmaceutical preparation comprising recombinant HcG
FERRING BV6 citations83
US10307459B2Jun 4, 2019
Pharmaceutical formulations of desmopressin
FERRING BV2 citations83
US9676835B2Jun 13, 2017
Pharmaceutical preparation comprising recombinant HcG
FERRING BV6 citations83
US8022106B2Sep 20, 2011
Tranexamic acid formulations
FERRING BV12 citations83
US7947739B2May 24, 2011
Tranexamic acid formulations
FERRING BV14 citations83
US11291708B2Apr 5, 2022
Human-derived recombinant FSH for controlled ovarian stimulation
FERRING BV5 citations82
US10624953B2Apr 21, 2020
Human-derived recombinant FSH for controlled ovarian stimulation
FERRING BV6 citations82
US10246499B2Apr 2, 2019
Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis
FERRING BV3 citations82
US9579305B2Feb 28, 2017
Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies
FERRING BV7 citations82
US7816489B2Oct 19, 2010
Methods for making intermediates and oxytocin analogues
FERRING BV10 citations82
US7091314B2Aug 15, 2006
Intermediates and methods for making heptapeptide oxytocin analogues
FERRING BV11 citations82
US11260102B2Mar 1, 2022
Manufacture of Degarelix
FERRING BV4 citations81
US10973870B2Apr 13, 2021
Methods of treating prostate cancer with GnRH antagonist
FERRING BV6 citations81
US10765721B2Sep 8, 2020
Manufacture of Degarelix
FERRING BV6 citations81
US9096335B2Aug 4, 2015
Fast dissolving pharmaceutical composition
FERRING BV12 citations81
US8361272B2Jan 29, 2013
Polyurethane elastomers
FERRING BV5 citations81
US11766468B2Sep 26, 2023
Method of treating prostate cancer with GnRH antagonist
FERRING BV2 citations80
US10695398B2Jun 30, 2020
Method of treating prostate cancer with GnRH antagonist
FERRING BV7 citations80
Showing the top 50 of 156 patents by PatentIndex Score.